Transparency Market Research

Global Next-Generation Sequencing Market Poised to Grow Exponentially, Asia Pacific to Exhibit Fastest CAGR

Transparency Market Research Report Added "Next Generation Sequencing Market" to its database.


Albany, NY -- (SBWIRE) -- 01/21/2016 -- The healthcare industry is not holding back from investing in the development of novel therapeutics. The growth of the market for next generation sequencing (NGS) is fuelled by continuous innovations and R&D activities in the healthcare industry aimed at increased accuracy, higher throughput, and affordable costs. Transparency Market Research's (TMR) upcoming report, titled "Next Generation Sequencing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023," focuses on analyzing the various factors influencing the growth trajectory exhibited by the global NGS market.

Browse Full Report:

Already a multibillion dollar industry, the global NGS industry will exhibit robust growth between 2015 and 2023. Next generation sequencing (NGS), also referred to as high-throughput sequencing, allows scientists to assemble and sequence billions of DNA reads. The advent of NGS has helped the healthcare sector to align the sequencing process by providing speed, flexibility, high throughput, and has reduced the cost of sequencing. Driven by the recent developments the overall cost of genome sequencing has already reached the much awaited US$1,000 mark, as reported by Illumina.

NGS enables generating hundreds of gigabases of nucleotide sequence data in not more than a single sequencing run. The market for NGS is growing at a rapid pace due to its increased adoption in clinical applications. NGS allows scanning of targeted genomes or whole genomes in a shorter span of time. In addition, the technology delivers the same at a very low cost, which has expanded its usage across diverse clinical applications such as cancer, HLA typing, diagnosis of infectious ailments, and inherited genetic disorders. For instance, NGS is increasingly used to trace tuberculosis outbreaks and hospital-acquired infections.

Get Sample of Report:

The TMR report aims to study the global NGS market on the basis of application, technology, end users, and geography. The market, based on application, can be segmented into personalized medicine, drug discovery, diagnostics, biomarker discovery, and others (including animal, agriculture, marine, and other studies). The most widely used sequencing technologies in healthcare institutions include sequencing by synthesis, pyrosequencing, ion semiconductor sequencing, single-molecule real-time sequencing, and sequencing by ligation. The report also aims to analyze the market in terms of end users, which include hospitals, clinics, pharmaceutical, biotechnology companies, and research institutes. Of these, academic institutes, government research institutes, and biopharmaceutical companies account for more than 65% of the revenue generated by the NGS market.

Geographically, the global next-generation sequencing market is spread across Asia Pacific, Europe, Latin America, North America, and the Middle East and Africa. Of these, North America accounts for the largest share of the global next generation sequencing market, trailed by Europe. However, Asia Pacific, according to TMR analysts, will exhibit the fastest CAGR in the forthcoming years.

About Transparency Market Research (TMR)
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453